Vishal R. Dhulipala (@dhulipalamd) 's Twitter Profile
Vishal R. Dhulipala

@dhulipalamd

IC @mountsinaiheart to @UofSC

ID: 1030060093067460613

linkhttp://www.linkedin.com/in/vishal-dhulipala-361602117 calendar_today16-08-2018 11:53:58

216 Tweet

372 Followers

886 Following

Koushik R. Reddy, MD, FACC, FACLM, DipABLM,LMI (@koushikreddymd) 's Twitter Profile Photo

If you want to change the paradigm of… For every ill, I have a pill and you get the bill. To that of… For every ill, I have a drill and you get the thrill. Here is an image that tells a thousand words. Keep moving and lift heavy things! Dr. Martha Gulati β™₯οΈπŸ«€β€οΈβ€πŸ©ΉπŸ‡¨πŸ‡¦

If you want to change the paradigm of…

For every ill, I have a pill and you get the bill.

To that of…

For every ill, I have a drill and you get the thrill.

Here is an image that tells a thousand words. 

Keep moving and lift heavy things! 
<a href="/DrMarthaGulati/">Dr. Martha Gulati β™₯οΈπŸ«€β€οΈβ€πŸ©ΉπŸ‡¨πŸ‡¦</a>
Richard Tanner (@richcardiomd) 's Twitter Profile Photo

Out now in JACC Journals, our analysis on the role of inflammation in risk prediction among HBR patients undergoing PCI, led by Dr. Manish Vinayak MD DM FSCAI πŸ‘‰ ⬆️ hsCRP is associated with high ischemic but not bleeding events πŸ‘‰ measuring hsCRP may help guide antiplatelet tx in HBR patients

Out now in <a href="/JACCJournals/">JACC Journals</a>, our analysis on the role of inflammation in risk prediction among HBR patients undergoing PCI, led by <a href="/manishvinayak/">Dr. Manish Vinayak MD DM FSCAI</a> 
πŸ‘‰ ⬆️  hsCRP is associated with high ischemic but not bleeding events
πŸ‘‰ measuring hsCRP may help guide antiplatelet tx in HBR patients
CRT Meeting (@crt_meeting) 's Twitter Profile Photo

#CRT2024 is offering a great hands-on opportunity! Don't miss the Endovascular Treatment of Peripheral Arterial Disease: A Hands-On Practicum. Visit this link for more information: bit.ly/3Tt6wl2

#CRT2024 is offering a great hands-on opportunity!  Don't miss the Endovascular Treatment of Peripheral Arterial Disease: A Hands-On Practicum.  Visit this link for more information: bit.ly/3Tt6wl2
Abhishek Chaturvedi MD (@iamdoctorabhi) 's Twitter Profile Photo

🚨 New session alert at #CRT2024 🚨 The countdown is on for the "Great Fellows Debate" CRT Meeting πŸŽ‰ Get ready for passionate discussions & riveting clash of perspectives, practice, ideas, and evidence by brightest young minds in the field. Don't miss out πŸ™ŒπŸ» #CardioTwitter

🚨 New session alert at #CRT2024 🚨

The countdown is on for the "Great Fellows Debate" <a href="/CRT_meeting/">CRT Meeting</a> πŸŽ‰

Get ready for passionate discussions &amp; riveting clash of perspectives, practice, ideas, and evidence by brightest young minds in the field. Don't miss out πŸ™ŒπŸ»

#CardioTwitter
Penn Cardiology (@penncardiology) 's Twitter Profile Photo

🚨 Penn Medicine Advanced #HeartFailure Specialist and Interim Medical Director for #HeartTransplant Aditya Parikh 🩺 is now seeing & accepting patients at Penn Cardiology's Downtown Robbinsville location!

🚨 <a href="/PennMedicine/">Penn Medicine</a> Advanced #HeartFailure Specialist and Interim Medical Director for #HeartTransplant <a href="/AdityaParikhMD/">Aditya Parikh</a> 🩺 is now seeing &amp; accepting patients at <a href="/PennCardiology/">Penn Cardiology</a>'s Downtown Robbinsville location!
Ethan Korngold, MD (@ekgpdx) 's Twitter Profile Photo

It’s a great day for the fight against PAD and #CLTI: first person treated commercially with the Esprit BTK Everolimus Eluting Resorbable Scaffold System. Great work Dr. Prakash Krishnan and team! #clifighters #abbottproud

It’s a great day for the fight against PAD and #CLTI: first person treated commercially with the Esprit BTK Everolimus Eluting Resorbable Scaffold System. 

Great work <a href="/PK_MountSinai/">Dr. Prakash Krishnan</a> and team!
#clifighters #abbottproud
Pier Pasquale Leone (@leoneppmd) 's Twitter Profile Photo

Our piece with Bernardo Cortese Antonio Colombo on 2-year outcomes after sirolimus-coated 🎈 among 2,123 patients from the largest EASTBOURNE Registry finally out on EuroIntervention. Very promising low event accrual between 1 and 2 years. πŸ”—: shorturl.at/SXH2u

Our piece with <a href="/BernardCortese/">Bernardo Cortese</a> <a href="/Antocol17/">Antonio Colombo</a> on 2-year outcomes after sirolimus-coated 🎈 among 2,123 patients from the largest EASTBOURNE Registry finally out on <a href="/EuroInterventio/">EuroIntervention</a>.

Very promising low event accrual between 1 and 2 years.

πŸ”—: shorturl.at/SXH2u
Gaurang Vaidya (@gaurang_md) 's Twitter Profile Photo

As an IMG, I wish someone had told me these things when applying for residency: 1. Avoid J1 visa if possible, even if seeking fellowshps. It hurts you at the end when looking for J1 waiver. Imagine going through 6+ years training and not getting a job.

Vishal R. Dhulipala (@dhulipalamd) 's Twitter Profile Photo

Anyone use a lead apron without a back protection ? (Front protection only) please share your thoughts as well. #interventionalcardiology #scai #radiationsafety